{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:56:51Z","timestamp":1791028611261,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbapap.2013.06.009","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T12:32:33Z","timestamp":1372163553000},"page":"2080-2088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of the binding site for fondaparinux on Beta2-glycoprotein I"],"prefix":"10.1016","volume":"1834","author":[{"given":"Alexey","family":"Kolyada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"De Biasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Beglova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2013.06.009_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0015","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"{beta}2-Glycoprotein I can exist in two conformations: implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0025","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","article-title":"Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure","volume":"18","author":"Bouma","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0030","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1093\/emboj\/18.22.6228","article-title":"Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome","volume":"18","author":"Schwarzenbacher","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"beta(2)-Glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1751-553X.2012.01414.x","article-title":"Recent developments in our understanding of the antiphospholipid syndrome","volume":"34","author":"De Groot","year":"2012","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0045","doi-asserted-by":"crossref","first-page":"e15345","DOI":"10.1371\/journal.pone.0015345","article-title":"A novel dimeric inhibitor targeting Beta2GPI in Beta2GPI\/antibody complexes implicated in antiphospholipid syndrome","volume":"5","author":"Kolyada","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0050","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1021\/bi960657q","article-title":"Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes","volume":"35","author":"Willems","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11926-010-0151-9","article-title":"New insights into the biology and pathobiology of beta2-glycoprotein I","volume":"13","author":"Giannakopoulos","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bbapap.2013.06.009_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2011.04301.x","article-title":"Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I","volume":"9","author":"Passam","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2796.2011.02362.x","article-title":"Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment","volume":"270","author":"Tripodi","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2007.02310.x","article-title":"Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2\u2032","volume":"5","author":"Pennings","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.bbapap.2013.06.009_bb0080","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1538-7836.2008.03021.x","article-title":"Platelet activation by dimeric beta(2)-glycoprotein I requires signaling via both glycoprotein Ibalpha and Apolipoprotein E Receptor 2\u2032","volume":"6","author":"Urbanus","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2011-03-344671","article-title":"A novel pathway for human endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"119","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte\u2013endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2","volume":"121","author":"Ramesh","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbapap.2013.06.009_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/BOR.0b013e328354ae8c","article-title":"Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome","volume":"24","author":"Wijetilleka","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0100","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1074\/jbc.M110176200","article-title":"Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome","volume":"277","author":"Guerin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0076-6879(93)22033-C","article-title":"Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin","volume":"222","author":"Olson","year":"1993","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00228146","article-title":"Gifa V. 4: a complete package for NMR data set processing","volume":"8","author":"Pons","year":"1996","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00211777","article-title":"1H, 13C and 15N chemical shift referencing in biomolecular NMR","volume":"6","author":"Wishart","year":"1995","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.str.2009.12.013","article-title":"Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids","volume":"18","author":"Lee","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein\u2013ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM \u2014 a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R","article-title":"Glycosaminoglycan\u2013protein interactions: definition of consensus sites in glycosaminoglycan binding proteins","volume":"20","author":"Hileman","year":"1998","journal-title":"Bioessays"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0140","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/nar\/gkq984","article-title":"Interpreting protein\/DNA interactions: distinguishing specific from non-specific and electrostatic from non-electrostatic components","volume":"39","author":"Privalov","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0897.1997.tb00301.x","article-title":"Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies","volume":"38","author":"Del Papa","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0150","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","article-title":"High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II","volume":"275","author":"Ma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0155","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0160","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2007.02680.x","article-title":"Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation","volume":"5","author":"Vega-Ostertag","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2009.07.004","article-title":"Patients with antiphospholipid syndrome display endothelial perturbation","volume":"34","author":"Cugno","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0170","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.152.2.653","article-title":"The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies","volume":"152","author":"Hunt","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0175","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.4049\/jimmunol.157.8.3744","article-title":"Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity","volume":"157","author":"Sheng","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1006\/jmbi.2000.4243","article-title":"Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance","volume":"304","author":"Hoshino","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0185","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1046\/j.1432-1327.2000.01174.x","article-title":"A hydrophobic sequence at position 313\u2013316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding","volume":"267","author":"Mehdi","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0190","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","article-title":"Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay","volume":"163","author":"Rand","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbapap.2013.06.009_bb0195","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0200","first-page":"363","article-title":"Molar antithrombin concentration in normal human plasma","volume":"13","author":"Conard","year":"1983","journal-title":"Haemostasis"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0205","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1074\/mcp.M400159-MCP200","article-title":"Pocketome via comprehensive identification and classification of ligand binding envelopes","volume":"4","author":"An","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbapap.2013.06.009_bb0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0959-440X(03)00075-7","article-title":"Ligand binding: functional site location, similarity and docking","volume":"13","author":"Campbell","year":"2003","journal-title":"Curr. Opin. Struct. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963913002409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963913002409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T15:52:50Z","timestamp":1688313170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963913002409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1570963913002409"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2013.06.009","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the binding site for fondaparinux on Beta2-glycoprotein I","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2013.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}